Related Experiment Video
Updated: Jun 6, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Neonatal bacterial meningitis
Abstract:
Neonatal bacterial meningitis (NM) continues to be a serious disease with an unchanging rate of adverse outcome of 20-60%, despite a worldwide decline in mortality. The 3 major pathogens in developed countries are: Group B streptococcus, gram negative rods and Lysteria monocytogenes. Signs and symptoms of NM may be subtle, unspecific, vague, atypical or absent. In order to exclude NM, all infants with proven or suspected sepsis should undergo lumbar puncture. Positive culture of cerebrospinal fluid may be the only way to diagnose NM and to identify the pathogen, as CSF parameters Smay be normal at early stages and NM may occur frequently (up to 30% of cases) in the absence of bacteraemia. When NM is suspected, treatment must be aggressive, as the goal is to achieve bactericidal concentration of antibiotics and to sterilize CSF as soon as possible. Antibiotics should be administered intravenously, at the highest clinically validated doses. Empiric antibiotic treatment should include agents active against all main pathogens; currently the recommended empiric treatment of NM is ampicillin, plus an aminoglycoside and a third-generation cephalosporn. Therapy should be reassessed after cultures and antibiotic susceptibility is available. Prevention of neonatal sepsis, early recognition of infants at risk, prompt treatment and future adjunctive therapies will improve prognosis. Finally, we present the first preliminary Italian data on GBS meningitis. Data are obtained from an area-based study conducted In Emilia-Romagna during 2003 to 2009.
Insights
Neonatal bacterial meningitis (NM) remains a severe threat with persistent adverse outcomes. Early diagnosis via lumbar puncture and aggressive, targeted antibiotic therapy are crucial for improving infant prognosis.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pediatric Neurology
Background:
- Neonatal bacterial meningitis (NM) presents a significant challenge with high rates of adverse outcomes (20-60%).
- Key pathogens include Group B Streptococcus, gram-negative rods, and Listeria monocytogenes.
- Clinical signs of NM can be subtle, nonspecific, or absent, complicating early diagnosis.
Purpose of the Study:
- To highlight the diagnostic challenges and critical treatment strategies for neonatal bacterial meningitis.
- To emphasize the importance of prompt lumbar puncture and aggressive antibiotic intervention.
- To present preliminary Italian data on Group B Streptococcus meningitis.
Main Methods:
- Review of diagnostic criteria and treatment guidelines for neonatal bacterial meningitis.
- Emphasis on cerebrospinal fluid (CSF) culture for pathogen identification.
- Discussion of recommended empiric antibiotic regimens, including ampicillin, aminoglycosides, and third-generation cephalosporins.
Main Results:
- Cerebrospinal fluid parameters may be normal in early stages, necessitating lumbar puncture even with suspected sepsis.
- Neonatal bacterial meningitis can occur without bacteremia in up to 30% of cases.
- Aggressive, high-dose intravenous antibiotic therapy is essential to achieve bactericidal concentrations and sterilize CSF.
Conclusions:
- Early recognition, prompt lumbar puncture, and appropriate, aggressive antibiotic treatment are vital for improving outcomes in neonatal bacterial meningitis.
- Prevention strategies and potential adjunctive therapies may further enhance prognosis.
- Preliminary Italian data on GBS meningitis from 2003-2009 are presented.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Cryptococcal Meningitis
Encephalitis l: Introduction

